These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7427966

  • 1. Tamoxifen in refractory metastatic carcinoma of the prostate.
    Glick JH, Wein A, Padavic K, Negendank W, Harris D, Brodovsky H.
    Cancer Treat Rep; 1980; 64(6-7):813-8. PubMed ID: 7427966
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of tamoxifen in metastatic carcinoma of the prostate.
    Glick JH, Wein A, Padavic K, Negendank W, Harris D, Brodovsky H.
    Cancer; 1982 Apr 01; 49(7):1367-72. PubMed ID: 6174204
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer.
    Lin CC, Hsu CH, Chen J, Tsai TC, Cheng AL, Pu YS.
    Anticancer Res; 2001 Apr 01; 21(2B):1385-90. PubMed ID: 11396219
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer.
    Dexeus F, Logothetis CJ, Samuels ML, Hossan E, von Eschenbach AC.
    Cancer Treat Rep; 1985 Apr 01; 69(7-8):885-6. PubMed ID: 4016795
    [Abstract] [Full Text] [Related]

  • 6. Hormonal therapy for metastatic male breast cancer.
    Kantarjian H, Yap HY, Hortobagyi G, Buzdar A, Blumenschein G.
    Arch Intern Med; 1983 Feb 01; 143(2):237-40. PubMed ID: 6824391
    [Abstract] [Full Text] [Related]

  • 7. A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion.
    Lissoni P, Vigano P, Vaghi M, Frontini L, Giuberti C, Manganini V, Casu M, Brivio F, Niespolo R, Strada G.
    Anticancer Res; 2005 Feb 01; 25(5):3597-9. PubMed ID: 16101186
    [Abstract] [Full Text] [Related]

  • 8. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G, Perdonà S, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Autorino R.
    J Urol; 2005 Dec 01; 174(6):2197-203. PubMed ID: 16280763
    [Abstract] [Full Text] [Related]

  • 9. [Cancer of the prostate: subcapsular orchiectomy].
    Cukier J, Rivain T.
    Bull Cancer; 1985 Dec 01; 72(6):543-8. PubMed ID: 4092105
    [Abstract] [Full Text] [Related]

  • 10. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A, Harvey HA, Santen RJ, Boucher A, White D, Bernath A, Dixon R, Richards G, Shafik A.
    Cancer Res; 1982 Aug 01; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [Abstract] [Full Text] [Related]

  • 11. A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.
    Dawson NA, Conaway M, Halabi S, Winer EP, Small EJ, Lake D, Vogelzang NJ.
    Cancer; 2000 Feb 15; 88(4):825-34. PubMed ID: 10679652
    [Abstract] [Full Text] [Related]

  • 12. Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.
    Chiappino I, Destefanis P, Addeo A, Galetto A, Cucchiarale G, Munoz F, Zitella A, Ferrando U, Fontana D, Ricardi U, Tizzani A, Bertetto O.
    Am J Clin Oncol; 2007 Jun 15; 30(3):234-8. PubMed ID: 17551298
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
    Smith DC, Chay CH, Dunn RL, Fardig J, Esper P, Olson K, Pienta KJ.
    Cancer; 2003 Jul 15; 98(2):269-76. PubMed ID: 12872344
    [Abstract] [Full Text] [Related]

  • 14. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL, Hollis DR, Rosner GL, Trump DL, Shapiro CL, Vogelzang NJ, Schilsky RL.
    Clin Cancer Res; 1997 Nov 15; 3(11):1977-84. PubMed ID: 9815587
    [Abstract] [Full Text] [Related]

  • 15. Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.
    Herrada J, Dieringer P, Logothetis CJ.
    J Urol; 1996 Feb 15; 155(2):620-3. PubMed ID: 8558675
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS, Pienta KJ, Fardig J, Olson K, Smith DC.
    Cancer; 2006 Apr 15; 106(8):1715-21. PubMed ID: 16534795
    [Abstract] [Full Text] [Related]

  • 17. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer.
    Ansari MS, Gupta NP.
    Urol Oncol; 2004 Apr 15; 22(5):415-20. PubMed ID: 15464923
    [Abstract] [Full Text] [Related]

  • 18. Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.
    Hussain M, Tangen CM, Lara PN, Vaishampayan UN, Petrylak DP, Colevas AD, Sakr WA, Crawford ED, Southwest Oncology Group.
    J Clin Oncol; 2005 Dec 01; 23(34):8724-9. PubMed ID: 16314632
    [Abstract] [Full Text] [Related]

  • 19. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M, Mitsiades CS, Bogdanos J, Dimopoulos T, Karamanolakis D, Milathianakis C, Tsintavis A.
    Clin Cancer Res; 2004 Jul 01; 10(13):4398-405. PubMed ID: 15240528
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma.
    Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ.
    Cancer; 2003 Feb 01; 97(3):561-7. PubMed ID: 12548597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.